Screener
OnKure Therapeutics, Inc. OKUR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from OnKure Therapeutics, Inc.’s reported figures.
The source filing: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206345
FAQ
- What is OnKure Therapeutics, Inc.'s invested capital?
- OnKure Therapeutics, Inc. (OKUR) reported invested capital of -$7.34M in Q1 2026.
- How has OnKure Therapeutics, Inc.'s invested capital changed year-over-year?
- OnKure Therapeutics, Inc.'s invested capital decreased by 45.2% year-over-year, from -$5.06M to -$7.34M.
- What is the long-term trend for OnKure Therapeutics, Inc.'s invested capital?
- Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s invested capital has grown at a -68.3% compound annual growth rate (CAGR), from -$72.88M to -$2.32M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about OnKure Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude